The cytopathicity of a simian immunodeficiency virus Mne variant is determined by mutations in Gag and Env

Journal of Virology

Volumn 71, Issue 10, 1997, Pages 7629-7639

  Kimata, Jason T ^a   Overbaugh, Julie ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENICITY; ARTICLE; CYTOPATHOLOGY; GENETIC RECOMBINATION; MOLECULAR CLONING; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SIMIAN IMMUNODEFICIENCY VIRUS; STEM CELL; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0030866072     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.10.7629-7639.1997     Document Type: Article

References (58)

1. Benveniste, R. E., R. W. Hill, L. J. Eron, U. M. Csaikl, W. B. Knott, L. E. Henderson, R. C. Sowder, K. Nagashima, and M. A. Gonda. 1990. Characterization of clones of HIV-1 infected HuT 78 cells defective in gag gene processing and of SIV clones producing large amounts of envelope glycoprotein. J. Med. Primatol. 19:351-366.
2. Bosch, M. L., P. L. Earl, K. Fargnoli, S. Picciafuoco, F. Giombini, F. Wong-Staal, and G. Franchini. 1989. Identification of the fusion peptide of primate immunodeficiency viruses. Science 244:694-697.
3. Cao, J-, I.-W. Park, A. Cooper, and J, Sodroski. 1996. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70:1340-1354.
4. Chackcrian, B., L. Rudensey, and J. Overbaugh. 1997. Specific N-linked and O-linked glycosylation modifications in the envelope VI domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71:7719-7727.
5. Chackerian, B., N. L. Haigwood, and J. Overbaugh. 1995. Characterization of a CD4-expressing macaque cell line that can detect virus after a single replication cycle and can be infected by diverse simian immunodeficiency virus isolates. Virology 213:386-394.
6. Cheng-Mayer, C., D. Seto, M. Tateno, and J. A. Levy. 1988. Biologic features of HIV-1 that correlate with virulence in the host. Science 240:80-82.
7. Cheng-Mayer, C., T. Shioda, and J. A. Levy. 1991. Host range, replicative, and cytopathic properties of human immunodeficiency virus type 1 are determined by very few amino acid changes in tat and gp120. J. Virol. 65:6931-6941.
8. Chernomordik, L., A. N. Chanturiya, E. Suss-Toby, E. Nora, and J. Zimmerberg. 1994. An amphipathic peptide from the C-terminal region of the human immunodeficiency virus envelope glycoprotein causes pore formation in membranes. J. Virol. 68:7115-7123.
9. Collman, R., J. W. Balliet, S. A. Gregory, H. Friedman, D. L. Kolson, N. Nathanson, and A. Srinivasan. 1992. An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunol deficiency virus type 1. J. Virol. 66:7517-7521.
10. Connor, R. I., and D. D. Ho. 1994. Human immunodeficiency virus type variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J. Virol. 68:4400-4408.
11. + T-lymphocyte decline and clinical progression in human immunodeficiency virus type 1-infected individuals. J. Virol. 67:1772-1777.
12. de Jong, J.-J., J. Goudsmit, W. Keulen, B. Klaver, W. Krone, M. Tersmette, and A. de Ronde. 1992. Human immunodeficiency virus type 1 clones chimeric for the envelope V3 domain differ in syncytium formation and replication capacity. J. Virol. 66:757-765.
13. Dorfman, T., A. Bukovsky, A. Ohagen, S. Hoglund, and H. G. Gottlinger. 1994. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:8180-8187.
14. Dorfman, T., J. Luban, S. P. Goff, W. A. Haseltine, and H. G. Göttlinger. 1993. Mapping of functionally important residues of a cysteine-histidine box in the human immunodeficiency virus type 1 nucleocapsid protein. J. Virol. 67:6159-6169.
15. Fenyö, E. M., J. Albert, and B. Åsjö. 1989. Replicative capacity, cytopathic effects and cell tropism of HIV. AIDS 3(Suppl.):S5-S12.
16. Fenyö, E. M., L. Morfeldt-Manson, F. Chiodi, B. Lind, A. von Gegerfelt, J. Albert, E. Olausson, and B. Åsjö. 1988. Distinct replicative and cytopathic characteristics of human immunodeficiency virus isolates. J. Virol. 62:4414-4419.
17. Fiore, J. R., A. Bjorndal, K. A. Peipke, M. Di Stefano, G. Angarano, G. Pastore, H. Gaines, E. M. Fenyö, and J. Albert. 1994. The biological phe- notype of HIV-1 is usually retained during and after sexual transmission. Virology 204:297-303.
18. Fisher, A. G., L. Ratner, H. Mitsuya, L. M. Marselle, M. E. Harper, S. Broder, R. C. Gallo, and F. Wong-Staal. 1986. Infectious mutants of HTLV-III with changes in the 3′ region and markedly reduced cytopathic effects. Science 233:655-659.
19. Gorelick, R. J., D. J. Chabot, A. Rein, L. E. Henderson, and L. O. Arthur. 1993. The two zinc fingers in the immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent. J. Virol. 67:4027-4036.
20. Gorelick, R. J., S. M. Nigida, J. W. Bess, L. O. Arthur, and L. E. Henderson. 1990. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA. J. Virol. 64:3207-3211.
21. Hirsch, V., D. Adger-Johnson, B. Campbell, S. Goldstein, C. Brown, W. R. Elkins, and D. C. Montefiori. 1997. A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3. J. Virol. 71:1608-1620.
22. Hirsch, V. M., P. Edmondson, M. Murphy-Corb, B. Arbeille, P. R. Johnson, and J. I. Mullins. 1989. SIV adaptation to human cells. Nature 341:572-573.
23. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59.
24. Johnston, P. B., J. W. Dubay, and E. Hunter. 1993. Truncations of the simian immunodeficiency virus transmembrane protein confer expanded virus host range by removing a block to virus entry into cells. J. Virol. 67:3077-3086.
25. Karlsson, A., K. Parsmyr, E. Sandström, E. M. Fenyö, and J. Albert. 1994. MT-2 cell tropism as prognostic marker for disease progression in human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 32:364-370.
26. Kimata, J. T., A. Mozaffarian, and J. Overbaugh. A lymph node-derived cytopathic simian immunodeficiency virus Mne variant replicates in non-stimulated peripheral blood mononuclcar cells. Submitted for publication.
27. Kodama, T., D. P. Wooley, Y. M. Naidu, H. W. Kestler III, M. D. Daniel, Y. Li, and R. C. Desrosiers. 1989. Significance of premature stop codons in env of simian immunodeficiency virus. J. Virol. 63:4709-4714.
28. Koot, M., A. H. V. Vos, R. P. M. Keet, R. E. Y. de Goede, M. Wouter Dercksen, F. G. Terpstra, R. A. Coutinho, F. Miedema, and M. Tersmette. 1992. HIV-1 biological phenotype in long-term infected individuals evaluated with an MT-2 cocultivation assay. AIDS 6:49-54.
29. Lee, S., W. Hu, A. G. Fisher, D. J. Looney, V. F. Kao, H. Mitsuya, L. Ratner, and F. Wong-Staal. 1989. Role of the carboxy-terminal portion of the HIV-1 transmembrane protein in viral transmission and cytopathogenicity. AIDS Res. Hum. Retroviruses 5:441-449.
30. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
31. Marthas, M. L., R. A. Ramos, B. L. Lohman, K. K. A. Van Rompay, R. E. Unger, C. J. Miller, B. Banapour, N. C. Pedersen, and P. A. Luciw. 1993. Viral determinants of simian immunodeficiency virus (SIV) virulence in rhesus macaques assessed by using attenuated and pathogenic molecular clones of SIVmac. J. Virol. 67:6047-6055.
32. Miedema, F., L. Meyaard, M. Koot, M. R. Klein, M. T. L. Roos, M. Groenink, R. A. M. Fouchier, A. B. Van't Wout, M. Tersmette, P. T. A. Schellekens, and H. Schuitemaker. 1994. Changing virus-host interactions in the course of HIV-1 infection. Immunol. Rev. 140:35-72.
33. Miller, M. A., M. W. Cloyd, J. Liebmann, C. R. Rinaldo, K. R. Islam, S. Z. S. Wang, T. A. Mietzner, and R. C. Montelaro. 1993. Alterations in cell membrane permeability by the lentivirus lytic peptlde (LLP-1) of HIV-1 transmembrane protein. Virology 196:89-100.
34. Miller, M. A., R. F. Garry, J. M. Jaynes, and R. C. Montelaro. 1991. A structural correlation between lentiviral transmembrane proteins and natural cytolytic peptides. AIDS Res. Hum. Retroviruses 7:511-519.
35. Miller, M. A., T. A. Mietzner, M. W. Cloyd, W. G. Robey, and R. C. Montelaro. 1993. Identification of a calmodulin binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein. AIDS Res. Hum. Retroviruses 9:1057-1066.
36. Morton, W. R., R. E. Benveniste, E. A. Clark, C.-C. Tsai, M. J. Gale, M. E. Thouless, J. Overbaugh, and M. G. Katze. 1989. Transmission of the simian immunodeficiency virus SIVmne in macaques and baboons. J. Med. Primatol 18:237-245.
37. Myers, G., B. H. Hahn, J. W. Mellors, L. E. Henderson, B. Korber, K. T. Jeang, F. E. McCutchan, and G. N. Pavlakis (ed.). 1995. Human retroviruses and AIDS. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
38. Novembre, F. J., P. R. Johnson, M. G. Lewis, D. C. Anderson, S. Klump, H. M. McClure, and V. M. Hirsch. 1993. Multiple viral determinants contribute to pathogenicity of the acutely lethal simian immunodeficiency virus SIVsmmPBj variant. J. Viro 67:2466-2474.
39. Ottmann, M., C. Gabus, and J. Darlix. 1995. The central globular domain of the nucleocapsid protein of human immunodeficiency virus type 1 is critical for virion structure and infectivity. J. Virol. 69:1778-1784.
40. Overbaugh, J., and L. M. Rudensey. 1992. Alterations in potential sites for glycosylation predominate during evolution of the simian immunodeficiency virus envelope gene in macaques. J. Virol. 66:5937-5948.
41. Overbaugh, J., L. M. Rudensey, M. D. Papenhausen, R. E. Benveniste, and W. R. Morton. 1991. Variation in simian immunodeficiency virus env is confined to V1 and V4 during progression to simian AIDS. J. Virol. 65: 7025-7031.
42. Ritter, G. D., Jr., M. J. Mulligan, S. L. Lydy, and R. W. Compans. 1993. Cell fusion activity of the simian immunodeficiency virus envelope protein is modulated by the intracytoplasmic domain. Virology 197:255-264.
43. Rudensey, L. M., J. T. Kimata, R. E. Benveniste, and J. Overbaugh. 1995. Progression to AIDS in macaques is associated with changes in the replication, tropism, and cytopathic properties of the simian immunodeficiency virus variant population. Virology 207:528-542.
44. Rudensey, L. M., J. T. Kimata, E. M. Long, B. Chackerian, and J. Overbaugh. Changes in the extracellular envelope glycoprotein of variants that evolve during the course of SIVMne infection affect neutralizing antibody recognition, syncytia formation and macrophage tropism, but not replication, cytopathicity or CCR-5 coreceptor recognition. Submitted for publication.
45. Rudensey, L. M., M. D. Papenhausen, and J. Overbaugh. 1993. Replication and persistence of simian immunodeficiency virus variants after passage in macaque lymphocytes and established human cell lines. J. Virol. 67:1727-1733.
46. Schuitemaker, H., M. Koot, N. A. Kootstra, M. W. Dercksen, R. E. Y. de Goede, R. P. van Steenwijk, J. M. A. Lange, J. K. M. E. Schattenkerk, F. Miedema, and M. Tersmette. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus populations. J. Virol. 66:1354-1360.
47. Slade, A., S. Jones, N. Almond, and P. Kitchin. 1993. Simian immunodeficiency virus (mac 251-32H) transmembrane protein sequence remains conserved throughout the course of infection in macaques. AIDS Res. Hum. Retroviruses 9:133-139.
48. Spies, C. P., G. D. Ritter, Jr., M. J. Mulligan, and R. W. Compans. 1994. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J. Virol. 68:585-591.
49. Srinivas, S. K., R. V. Srinivas, G. M. Anantharamaiah, R. W. Compans, and J. P. Segrest. 1993. Cytosolic domain of the HIV envelope glycoprotein binds to CaM and inhibits CaM-regulated proteins. J. Biol. Chem. 268:22895-22899.
50. Tencza, S. B., T. A. Mietzner, and R. C. Montelaro. 1997. Calmodulin-binding function of LLP segments from the HIV type 1 transmembrane protein is conserved among natural sequence variants. AIDS Res. Hum. Retroviruses 13:263-269.
51. Tersmette, M., R. A. Gruters, F. De Wolf, R. E. Y. De Goede, J. M. A. Lange, P. T. A. Schellekens, J. Goudsmit, H. G. Huisman, and F. Miedema. 1989. Evidence for a role of virulent human immunodeficiency virus (HIV) variants in the pathogenesis of acquired immunodeficiency syndrome: studies on sequential HIV isolates. J. Virol. 63:2118-2125.
52. Tersmette, M., J. M. A. Lange, R. E. Y. DeGoede, F. DeWolf, J. K. M. Eeftink-Schattenkerk, P. T. A. Schellekens, R. A. Coutinho, J. G. Huisman, J. Goudsmit, and F. Miedema. 1989. Association between biological properties of human immunodeficiency virus variants and risk for AIDS and AIDS mortality. Lancet i:983-985.
53. Valentin, A., J. Albert, E. M. Fenyo, and B. Asjo. 1994. Dual tropism for macrophages and lymphocytes is a common feature of primary human immunodeficiency virus type 1 and 2 isolates. J. Virol. 68:6684-6689.
54. Yang, C., C. P. Spies, and R. W. Compans. 1995. The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc. Natl. Acad. Sci. USA 92:9871-9875.
55. You, J. C., and C. S. McHenry. 1994. Human immunodeficiency virus nucleocapsid protein accelerates strand transfer of the terminally redundant sequences involved in reverse transcription. J. Biol. Chem. 269:31491-31495.
56. + T cells by non-syncytium-inducing macrophage-tropic human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91:10237-10241.
57. Zhang, H., G. Doroadula, P. Alur, M. A. Laughlin, and R. J. Pomerantz. 1996. Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription. Proc. Natl. Acad. Sci. USA 93:12519-12524.
58. Zingler, K., and D. R. Littman. 1993. Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases Env incorporation into particles and fusogenicity and infectivity. J. Virol. 67: 2824-2831.